Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

27.95 +2.54 (+10.00%)
Official Closing Price Updated: 7:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stevanato Group S.p.A. Ordinary Shares

< Previous 1 2 3 4 5 Next >
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth
From Stevanato Group
Via Business Wire
The Latest Analyst Ratings for Stevanato Group
 
Via Benzinga
Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
A Preview Of Stevanato Group's Earnings
 
Via Benzinga
Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023
From Stevanato Group S.p.A.
Via Business Wire
Recap: Stevanato Group Q2 Earnings
  Stevanato Group (NYSE:STVN) reported its Q2 earnings results on Thursday, August 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Analyst Ratings for Stevanato Group
Analysts have provided the following ratings for Stevanato Group (NYSE:STVN) within the last quarter: 
Via Benzinga
Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports Third Quarter 2022 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million. 
Via Benzinga
Stevanato Group and Gerresheimer AG Present EZ-fill Smart™, a New and Innovative Ready-To-Use Vial Platform
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group and DWK Life Sciences Sign Non-Exclusive Distribution Agreement for EZ-fill® Platform Products
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Third Quarter 2022 Financial Results on November 8, 2022
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group and Gerresheimer AG Announce Collaboration on the Development of an Innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports Second Quarter 2022 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Second Quarter 2022 Financial Results on August 4, 2022
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Releases Sustainability Report 2021, Highlighting the Environmental, Social and Governance (ESG) Performance of the Group
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Announces Voting Results from its Annual General Meeting
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Adding New Capacity in Italy Amid Growing Demand for Its Market-Leading Solutions
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports First Quarter 2022 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
Stevanato Group Publishes Materials for 2022 Annual General Meeting
From Stevanato Group
Via Business Wire
Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body Device
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report First Quarter 2022 Financial Results on May 10, 2022
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Files Amendment No.1 to Its 2021 Annual Report on Form 20‑F/A
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Stevanato Group S.p.A.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.